G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

Institut Jules Bordet, Brussels

MHAT for Womens Health - Nadezhda OOD, Sofia

ARENSIA Exploratory Medicine Phase I Unit, The Institute of Oncology, Chisinau

UZ Leuven, Leuven

Sarah Cannon Research Institute at Tennessee Oncology, Nashville

Northwestern University - Feinberg School of Medicine, Chicago

Stephenson Cancer Center, Oklahoma City

Beverly Hills Cancer Center, Beverly Hills

Stanford Women Cancer Center, Stanford

University of North Carolina at Chapel Hill, Chapel Hill

ARENSIA Exploratory Medicine LLC, Tbilisi

VU University Medical Center, Amsterdam

University Medical Center Groningen, Groningen

Erasmus Medical Center, Rotterdam

Spizhenko Clinic, Kiev